Of potential therapeutic interest, topical ocular delivery of the p38 inhibitor BIRB 796 showed a neuroprotective effect in animal models of glaucoma, although the intraocular pressure was not affected [129]. The gene discussed is MAPK1; the disease is glaucoma.